

Publisher: Karger
E-ISSN: 1423-0194|103|6|758-770
ISSN: 0028-3835
Source: Neuroendocrinology, Vol.103, Iss.6, 2015-12, pp. : 758-770
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects
Neuroendocrinology, Vol. 101, Iss. 4, 2015-04 ,pp. :





